Suzuki S, Franco-Saenz R, Tan S Y, Mulrow P J
J Clin Invest. 1980 Oct;66(4):757-62. doi: 10.1172/JCI109913.
To study the effect of kallikrein on renal renin release, we superfused rat renal cortical slices with 3.5 to 140 milliesterase units (mEU)/ml of purified rat urinary kallikrein. Kallikrein was a potent stimulus of renin release. Renin rose in a dose-dependent fashion from 70 mEU/ml to 140 mEU/ml. The response to 140 mEU/ml was greater than that seen with maximal doses of prostaglandin E2 (170 +/- 43%, P < 0.05) and at least the same as isoproterenol (242 +/- 49% increase), or dibutyryl cyclic AMP (272 +/- 40%). Trypsin was ineffective under these experimental conditions. Kallikrein-stimulated renin release was completely abolished by trasylol, whereas bradykinin did not increase renin production, indicating that kallikrein's effect is not mediated via kinin generation. There was no demonstrable acid activation or kallikrein activation of the superfusate and chromatography on Sephacryl S-200 revealed a single renin peak of -40,000 mol wt, suggesting that all of the renin release was in the active form. The data suggests that urinary kallikrein acts directly on the rat kidney to release renin, possibly via proteolytic conversion of prorenin to active renin. Our results support the concept that kallikrein may be an endogenous activator of prorenin in the kidney.
为研究激肽释放酶对肾素释放的影响,我们用3.5至140毫酯酶单位(mEU)/毫升的纯化大鼠尿激肽释放酶对大鼠肾皮质切片进行了灌流。激肽释放酶是肾素释放的有效刺激物。肾素从70 mEU/毫升至140 mEU/毫升呈剂量依赖性升高。对140 mEU/毫升的反应大于最大剂量前列腺素E2所产生的反应(170±43%,P<0.05),且至少与异丙肾上腺素(增加242±49%)或二丁酰环磷腺苷(增加272±40%)相同。在这些实验条件下,胰蛋白酶无效。抑肽酶可完全消除激肽释放酶刺激的肾素释放,而缓激肽并未增加肾素生成,这表明激肽释放酶的作用并非通过激肽生成介导。未发现灌流液有明显的酸激活或激肽释放酶激活,并且在Sephacryl S - 200上进行色谱分析显示肾素的单一峰值为 - 40,000摩尔质量,这表明所有释放的肾素均为活性形式。数据表明,尿激肽释放酶可能直接作用于大鼠肾脏以释放肾素,可能是通过将肾素原蛋白水解转化为活性肾素。我们的结果支持激肽释放酶可能是肾脏中肾素原的内源性激活剂这一概念。